Nice to read a fair and honest article about EPGL's potential...
"Penny stocks that manage to their share price and try to pump up their share price, particularly when they’re not even in the process of raising money, are frightening."
"I would be really, really curious to see whether this InWith company is able to get any kind of meaningful venture capital funding that gets anywhere close to the $100 million valuation EPGL already trades at, let alone $500 million — even in today’s very loose venture capital funding environment, that seems like a stretch.
This might be just my skepticism coming through, but the little hairs on the back of my neck stand up straight when a company gets a $100 million valuation with $80 million of that hypothetical value held by the two principals, has a hyper-promotional CEO who tries to talk up the share price, and doesn’t offer audited financial statements. "
"InWith, their putative partner, doesn’t seem to have anything else ‘real’ about it — it’s a private company that has a website about some augmented reality and ‘bionics’ type stuff, but no real information… so why on earth is it InWith that’s seeking venture funding to license or buy out EPGL, and not EPGL itself that’s trying to actually fund development? I have no idea. So far, what InWith has provided is an AutoCAD design of the “EPGL Omega Contact Lens” that will supposedly be controlled by a smartphone.
I do know that CEO Michael Hayes is frighteningly promotional, most of the conference call was all about how it’s “time to get in” and there will be new deals and relationships that will supercharge the share price. They even tweeted out a week before the last press release that “We hit .065 just weeks ago on a newsletter article. The major update we have nxt Tues is much bigger to EPGL future than that was.”
Market Data 
Markets 
AI
